Delivery Order SPE2DB24D1205-SPE2DB25FCTAW

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,580.11 firm fixed-price delivery order is for the supply of 4566883995 - LURASIDONE HCL 20 MG TABLET UD 30S. The contract has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,463.77 firm fixed-price delivery order is for the supply of 500 tablets of 20 mg Lurasidone HCl, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB25FAHA2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,130.06, is a Delivery Order for the supply of 4566770655 ! LURASIDONE HCL 40 MG TABLET 500S. The contract has an ultimate completion date of December 20, 2024 and is a Firm Fixed Price contract type. The place of performance is Conshohocken, PA...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAHM5, was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,836.92 fixed-price delivery order is for the provision of 500 tablets of the pharmaceutical drug Lurasidone Hydrochloride 40 mg. The contract has an ultimate completion date of December 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,303.40 firm fixed price delivery order is for the supply of 500 tablets of 80 mg Lurasidone HCl, a medication used to treat mental health conditions. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Lurasidone HCL 20 mg tablets, a medication used to treat certain mental health conditions. The contract has a firm fixed-price pricing structure and a ceiling value of $1,174.20. It is not designated as a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,959.35 firm fixed-price delivery order is for the supply of LATUDA 80 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $14,542.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of LATUDA 80 MG TABLET 30S, a pharmaceutical product. The award has a firm fixed price pricing type and an ultimate completion date of September 23, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare...
This federal contract award is for the delivery of Latuda 60 mg tablets to the Defense Logistics Agency (DLA). The $1,536.39 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 7, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCTAW
    Delivery Order

This federal contract award SPE2DB24D1205|SPE2DB25FCTAW, valued at $2,309.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566930988 - LURASIDONE HCL 20 MG TABLET UD 30S.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen is the prime contractor, and there is no mention of any major subcontractors in the provided information.

Generated 5/21/25, 10:12 AM